Agenzie
Exclusive: Canada told drugmakers it would limit scope of some new price rules
Daily strides may mean longer life for older women
Medicare's 'Primary Care First' Program Has Its Skeptics
'We had no idea': overdose victim's dad testifies in J&J Oklahoma opioid trial
Atezolizumab-Bevacizumab Misses Survival Endpoint in Metastatic RCC
Being Transgender Not a Mental Disorder, WHO Says
The term gender incongruence is used by the WHO to describe people whose gender identity is different from the gender they were assigned at birth.
Breaking the Ultrasound Barrier to Fight Disease
Ultrasound to open the blood-brain barrier in Alzheimer’s disease is the latest in the growing field of focused ultrasound. With focused ultrasound, doctors use the sound waves to actively treat a condition rather than passively produce images of it.
First Trial of Opioid Maker Begins
The case, Oklahoma vs. J&J, is being closely watched by lawyers in nearly 1,900 similar state and federal cases in the U.S.
FDA OKs Wearable Device for Migraine Pain
The FDA has cleared a noninvasive device that uses smartphone-controlled electronic pulses to relieve acute migraine pain.
Insomnia, sleep apnea diagnoses up sharply in U.S. Army
Violence Continues to Stymie Ebola Response Efforts in DRC
'Bad' Cholesterol, Rare Alzheimer's May Be Linked
If research confirms that high cholesterol plays a role in Alzheimer’s disease, officials may need to reduce our target levels for “bad” LDL cholesterol, the study author said.